Self-pay GLP-1 care with multiple plan displays

Get Thin MD review

Get Thin MD offers self-pay GLP-1 prescribing and delivery, but its price cards and FAQ disagree. Compare the exact selected product and full charge: the $169 semaglutide equivalent requires a three-month upfront or financed plan.

Check your care options.

Confirm the medication, clinical access and recurring bill for your own plan.

Visit Get Thin MDOfficial provider website. No affiliate relationship is currently listed.

A fit for

Readers comparing a defined self-pay prescription and ongoing contact who can obtain a reconciled product-specific quote.

  • Separate monthly and three-month product cards are displayed.
  • The program describes medication, clinical review, coaching and shipping.
  • Pharmacy partners and a conditional guarantee are identified.

Tradeoffs to understand

Buyers choosing the lowest displayed rate without a plan qualifier or expecting instant clinical access and an unconditional refund.

  • FAQ prices differ from the main product cards.
  • The cancellation documents give 72-hour and 36-hour descriptions.
  • Round-the-clock messaging language differs from the clinical hours in the terms.
In this review

Reconcile the product cards before using the headline

Get Thin MD can be compared for a self-pay prescription service with delivery and continuing contact. Its main GLP-1 cards show compounded semaglutide at $199 per month or $169 per month on a three-month plan. The footnote requires upfront payment or a buy-now-pay-later arrangement for that longer option. Tirzepatide’s monthly card shows $299. Those are identifiable offers, but the page does not provide one consistent set of prices. [1]

Its cost FAQ instead calls semaglutide $119 and tirzepatide $179 per month, while the homepage ties the $119 rate to a twelve-month plan. Do not choose one display as the universally available charge. Obtain the actual product, supply, cash due and renewal; financing also needs its own agreement. A three-month equivalent is not a one-month trial, and an arithmetic total is not a confirmed invoice. [1] [2]

A message can be sent at any time without an immediate reply

The program page advertises unlimited, round-the-clock support. The additional weight-program terms describe clinical hours on weekdays from nine to five Pacific time and provider message review within forty-eight hours or sooner. They also use twenty-four-hour doctor-chat language elsewhere. A portal’s availability and a clinician’s response are therefore different things to settle. The selected plan should identify the prescriber, required check-ins and the route for medication concerns. [1] [3]

The stopping instructions are not fully aligned

The separate cancellation policy requires notice at least seventy-two hours before billing and says another cycle can be charged if notice is late. Additional weight-program terms say cancellation takes effect in thirty-six hours and list phone, email or not completing a refill questionnaire as stopping methods. The general subscription section leaves cutoff details to purchase terms. Obtain one written applicable procedure rather than assume that silence or the shorter interval always stops the next charge. [3] [4]

The policy says ordinary cancellation does not earn a refund. Medical disqualification has special provisions, but its descriptions differ between a full current-cycle refund and remaining charges, and medication already ordered creates another limitation. The terms also make a paid program membership fee nonrefundable. The consequence depends on the actual order and agreement; cancelling future renewals is not the same event as recovering money already paid. [3] [4]

The guarantee is a conditional weight-program provision

The policy offers reimbursement for the first four months of billing if an eligible new subscriber fails to lose 10% of reported baseline weight after sixteen weeks. It requires sixteen consecutive weeks of clinician-directed weekly compounded semaglutide or tirzepatide and excludes prior weight-loss medication outside the program during the preceding twelve months. Verification includes a doctor’s attestation. These conditions are not a personal dose instruction or a universal satisfaction trial. [4]

A buyer should clarify the full claim procedure and its relationship to the other nonrefund clauses before relying on it. The website’s testimonial or program-average figures do not promise an individual result. A refund condition also cannot establish that a compounded preparation reproduces an approved product’s trial outcomes. The clinical decision should stand independently of reimbursement eligibility. [2] [4]

Choose the care model once the bill is settled

The homepage names Triad Rx, Precision Medicine, RedRock Pharmacy and Beaker Pharmacy & Compounding; the terms assign a network dispenser. Confirm the actual pharmacy for the prescription. FDA does not verify compounded drugs for safety, effectiveness or quality before marketing, and they are distinct from approved generics. I would shortlist Get Thin MD when the actual preparation, follow-up and full commitment fit the need. If insurance navigation or a more explicit response schedule is the main requirement, compare that pathway directly. [2] [3] [5]

Understanding the cost

Main cards: semaglutide $199/month or $169/month on a three-month plan paid upfront or financed; tirzepatide $299/month. FAQ instead says semaglutide $119 and tirzepatide $179 monthly; homepage ties $119 to 12 months. Obtain the applicable full charge, supply, renewal and financing conditions. No total invoice inferred.

Build your cost estimate

Sources

  1. Get Thin MD: product-specific price cards, upfront-plan footnote and conflicting FAQ rates
  2. Get Thin MD: current treatment menu, plan qualifiers, expanded pharmacy and service answers
  3. Get Thin MD: payment, clinical access and additional weight-program terms
  4. Get Thin MD: cancellation notice, medical-disqualification refunds and conditional weight-loss guarantee
  5. FDA: compounded medicines, generic-drug distinction and pharmacy oversight

This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.

Affiliate partner

Before you go

Explore this option
Continue to your original choiceWe may earn a commission if you choose our partner. These services may differ in products, fees and clinical access.